4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 298 | 1,248 | 500 | 162 | 1,219 |
| Gross Profit | 298 | 1,248 | 500 | 162 | 1,219 |
| Operating Expenses | 30,404 | 29,967 | 26,995 | 28,588 | 27,611 |
| Operating Income | -30,106 | -28,719 | -26,495 | -28,426 | -26,392 |
| Other Income | 1,424 | 1,340 | 804 | 340 | 54 |
| Pre-tax Income | -28,682 | -27,379 | -25,691 | -28,086 | -26,338 |
| Net Income Continuous | -28,682 | -27,379 | -25,691 | -28,086 | -26,338 |
| Net Income | $-28,682 | $-27,379 | $-25,691 | $-28,086 | $-26,338 |
| EPS Basic Total Ops | -0.88 | -0.84 | -0.79 | -0.87 | -0.82 |
| EPS Basic Continuous Ops | -0.88 | -0.84 | -0.79 | -0.87 | -0.82 |
| EPS Diluted Total Ops | -0.88 | -0.84 | -0.79 | -0.87 | -0.82 |
| EPS Diluted Continuous Ops | -0.88 | -0.84 | -0.79 | -0.87 | -0.82 |
| EBITDA(a) | $-29,472 | $-27,936 | $-25,739 | $-27,491 | $-25,404 |